炎性细胞因子、MAOB基因13内含子G/A、SNCA基因rs3822086位点多态性与帕金森病的相关性研究OA
Study on the correlation between IL-related inflammatory factor expression,MAOB gene 13 intron G/A,SNCA gene rs3822086 locus polymorphism and Parkinson's disease
目的 探讨IL相关炎症因子表达水平、MAOB基因 13 内含子G/A(MAOB-13G/A)多态性、SNCA基因rs3822086 位点多态性和帕金森病(PD)的相关性.方法 以 94 例PD患者、110 例健康对照者为研究对象,应用ELISA法测定其IL-1α、IL-6、IL-8、IL-10 的水平,采用限制性片段长度多态性聚合酶链反应(PCR-RFLP)检测MAOB-13G/A、SNCA-rs3822086 位点多态性基因分型.比较两组间不同MAOB、SNCA基因型患者IL相关炎症因子的表达水平.结果 PD组及正常对照组MAOB-13G/A和SNCA-rs3822086 位点基因型分布差异无统计学意义(均P>0.05).早期组、中期组及晚期组血清IL-6 水平差异有统计学意义(P<0.05),血清IL-1α、IL-8、IL-10 水平差异无统计学意义(均P>0.05).PD组血清IL-1α、IL-8、IL-10 水平显著高于正常对照组(均P<0.05),两组间血清IL-6 水平差异无统计学意义(P>0.05).与正常对照组比较,PD组MAOB基因G/G、A/A基因型患者血清IL-1α、IL-8、IL-10 水平显著升高(均P<0.05),血清IL-6 水平差异无统计学意义(均P>0.05);G/A基因型患者血清IL-8、IL-10 水平显著升高(均P<0.05),血清IL-1α、IL-6水平差异无统计学意义(均P>0.05).与正常对照组比较,PD组SNCA基因C/C和C/T基因型患者血清IL-8、IL-10 水平显著升高(均P<0.05),血清IL-1α、IL-6 差异无统计学意义(均P>0.05);T/T基因型患者血清IL-1α、IL-8 显著升高(均P<0.05),血清IL-6 水平显著降低(P<0.05),血清IL-10 水平差异无统计学意义(P>0.05).结论 血清IL-6 水平的升高与PD病情加重有关,血清IL-1α、IL-8、IL-10 水平升高可能是PD发生的危险因素.MAOB-13G/A、SNCA-rs3822086 位点不同基因型可改变IL-1α、IL-10 水平,进而影响PD的病情进展.SNCA T/T基因型可能是引起低IL-6 水平的遗传因素.
Objective To explore the correlation between IL-related inflammatory factor expression,MAOB gene 13 intron G/A(MAOB-13G/A)polymorphism,SNCA gene rs3822086 locus polymorphism and Parkinson's disease(PD).Methods A total of 94 PD patients and 110 healthy controls were enrolled in this study.The levels of IL-1α,IL-6,IL-8 and IL-10 were determined by ELISA,and the genotypes of MAOB-13G/A and SNCA-rs3822086 locus polymorphisms were detected by restriction fragment length polymorphism polymerase chain reaction(PCR-RFLP).The levels of IL-related inflammatory factors in patients with different MAOB and SNCA genotypes were compared between the two groups.Results There was no significant difference in genotype distribution of MAOB-13G/A and SNCA-rs3822086 locus genotypes between PD group and normal control group(all P>0.05).There were significant differences in serum IL-6 levels among the early stage group,the middle stage group and the late stage group(P<0.05),while there was no statistically significant difference in serumIL-1α,IL-8,and IL-10 levels(all P>0.05).The serum levels of IL-1α,IL-8 and IL-10 in PD group were significantly higher than those in normal control group(all P<0.05),while there was no statistically significant difference in serum IL-6 level(P>0.05).Compared with those in normal control group,the serum levels of IL-1α,IL-8 and IL-10 in PD group with MAOB G/G and A/A genotypes were significantly increased(all P<0.05),while there was no statistically significant difference in serum IL-6 levels(P>0.05);the serum levels of IL-8 and IL-10 in PD group with MAOB G/A genotype were significantly increased(all P<0.05),while there was no statistically significant difference in serum IL-1α and IL-6 levels(all P>0.05).Compared with those in normal control group,the serum levels of IL-8 and IL-10 in PD group with SNCA C/C and C/T genotypes were significantly increased(all P<0.05),while there was no statistically significant difference in serum IL-1α and IL-6 levels(all P>0.05);the serum levels of IL-1α and IL-8 in PD group with T/T genotype were significantly increased(all P<0.05),while the serum IL-6 level was significantly decreased(P<0.05),and there was no statistically significant difference in serum IL-10 levels(P>0.05).Conclusions The increase in serum IL-6 level is related to the aggravation of PD,and the increase in serum IL-1α,IL-8,and IL-10 expression levels may be risk factors for PD.The different genotypes of MAOB-13G/A and SNCA-rs3822086 loci can change the levels of IL-1α and IL-10,thereby affecting the progression of PD.The SNCA T/T genotype may be a genetic factor causing low IL-6 level.
宋秋霞;刘鑫;郭淼;张晓莺
830002 乌鲁木齐新疆生产建设兵团医院神经内科830002 乌鲁木齐新疆生产建设兵团医院神经内科830002 乌鲁木齐新疆生产建设兵团医院神经内科830002 乌鲁木齐新疆生产建设兵团医院神经内科
医药卫生
帕金森病IL相关炎症因子MAOB基因多态性SNCA基因多态性
Parkinson's diseaseIL-related inflammatory factorMAOB gene polymorphismSNCA gene polymorphism
《临床神经病学杂志》 2026 (1)
31-35,5
NSFC-新疆联合基金重点支持项目(U1603281)
评论